Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Bacchetta, Justine ^a,b   Chun, Rene F ^a   Gales, Barbara ^a   Zaritsky, Joshua J ^a   Leroy, Sandrine ^c   Wesseling Perry, Katherine ^a   Boregaard, Niels ^d   Rastogi, Anjay ^a   Salusky, Isidro B ^a   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE LYON   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; ERGOCALCIFEROL; HEPCIDIN; MESSENGER RNA; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; VITAMIN D;

ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CAMP GENE; CELL SUBPOPULATION; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENE; GENE REPRESSION; GENETIC ASSOCIATION; HAMP GENE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; METABOLITE; MONOCYTE; PERITONEAL DIALYSIS; PERITONEUM MACROPHAGE; PERITONITIS; PHENOTYPE; SINGLE DRUG DOSE; YOUNG ADULT; ADOLESCENT; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PRESCHOOL CHILD; RENAL INSUFFICIENCY, CHRONIC;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; HEPCIDINS; HUMANS; MACROPHAGES, PERITONEAL; MALE; PERITONEAL DIALYSIS; PERITONITIS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; YOUNG ADULT;

EID: 84920124433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116530     Document Type: Article

References (52)

1. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, et al. (2008) Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 3: 1144-1151.
2. Holick MF (2005) Vitamin D deficiency in CKD: why should we care? Am J Kidney Dis 45: 1119-1121.
3. Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, et al. (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatric nephrology 21: 151-159.
4. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58.
5. Group KW (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 53: S11-104.
6. Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, et al. (2007) Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract 107: c109-116.
7. Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23: 1831-1836.
8. Belostotsky V, Mughal MZ, Berry JL, Webb NJ (2008) Vitamin D deficiency in children with renal disease. Arch Dis Child 93: 959-962.
9. Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, et al. (2010) The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab 95: 1741-1748.
10. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, et al. (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7: 216-223.
11. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, et al. (2009) Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 76: 977-983.
12. Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, et al. (2011) Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int 79: 112-119.
13. Brown AJ, Slatopolsky E (2007) Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab 3: 134-144.
14. Li M, Batuman V (2009) Vitamin D: a new hope for chronic kidney disease? Kidney Int 76: 1219-1221.
15. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90: 387-392.
16. Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4: 80-90.
17. Zehnder D, Quinkler M, Eardley KS, Bland R, Lepenies J, et al. (2008) Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 74: 1343-1353.
18. Wesseling-Perry K, Salusky IB (2009) Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens 18: 308-314.
19. Chonchol M, Kendrick J, Targher G Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med 43: 273-282.
20. Hewison M (2011) Antibacterial effects of vitamin D. Nat Rev Endocrinol 7: 337-345.
21. Dalrymple LS, Go AS (2008) Epidemiology of acute infections among patients with chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN 3: 1487-1493.
22. Perez-Fontan M, Lueiro F (2006) Escherichia coli peritonitis in patients undergoing peritoneal dialysis: a serious problem that may get worse. Perit Dial Int 26: 174-177.
23. Li PK, Chow KM (2011) Infectious complications in dialysis-epidemiology and outcomes. Nat Rev Nephrol 8: 77-88.
24. Nessim SJ (2011) Prevention of peritoneal dialysis-related infections. Semin Nephrol 31: 199-212.
25. Zaritsky J, Warady BA (2011) Peritoneal dialysis in infants and young children. Seminars in nephrology 31: 213-224.
26. Lewis S, Holmes C (1991) Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 11: 14-21.
27. Goldstein CS, Garrick RE, Polin RA, Gerdes JS, Kolski GB, et al. (1986) Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis. J Leukoc Biol 39: 457-464.
28. Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, et al. (1985) Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 49: 212-218.
29. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD (1984) Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 26: 733-740.
30. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
31. Bacchetta J ZJ, Sea JL, Chun RF, Lisse TS, Zavala K, et al. (2013) Suppression of iron-regulatory hepcidin by vitamin D. Journal of the American Society for Nephrology [ePub ahead of print].
32. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo Jr CA, et al. (2009) Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis. Clin Infect Dis.
33. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD (2010) Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 21: 353-361.
34. Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, et al. (1983) Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 147: 1018-1029.
35. Lewis S, Holmes C (1991) Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1. Perit Dial Int 11: 14-21.
36. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, et al. (1993) Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 43: 641-648.
37. Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, et al. (2002) Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Perit Dial Int 22: 663-669.
38. Bouts AH, Davin JC, Krediet RT, Schroder CH, Monnens LA, et al. (2005) IgG and complement receptor expression in children treated by peritoneal dialysis. Pediatr Nephrol 20: 1161-1167.
39. Shany S, Rapoport J, Zuili I, Gavriel A, Lavi N, et al. (1991) Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. Kidney Int 39: 1005-1011.
40. Hayes ME, O'Donoghue DJ, Ballardie FW, Mawer EB (1987) Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients. FEBS Lett 220: 307-310.
41. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, et al. (2009) Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182: 4289-4295.
42. Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, et al. (2011) Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 12: 1648-1665.
43. Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, et al. (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 107: 22593-22598.
44. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788.
45. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433.
46. Ganz T (2009) Iron in innate immunity: starve the invaders. Curr Opin Immunol 21: 63-67.
47. Drakesmith H, Prentice AM (2012) Hepcidin and the iron-infection axis. Science 338: 768-772.
48. Hewison M (2010) Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 321: 103-111.
49. Tjabringa GS, Rabe KF, Hiemstra PS (2005) The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Pulm Pharmacol Ther 18: 321-327.
50. Cowland JB, Johnsen AH, Borregaard N (1995) hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 368: 173-176.
51. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, et al. (2013) Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28: 46-55.
52. Sorensen O, Cowland JB, Askaa J, Borregaard N (1997) An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206: 53-59.